Zidovudine-Related Thrombocytopenia Simulating Rapid Growth of Kaposi's Sarcoma
Autor: | James H. Barnett, Ian H. Gilson |
---|---|
Rok vydání: | 1991 |
Předmět: |
Pathology
medicine.medical_specialty business.industry Human immunodeficiency virus (HIV) Dermatology General Medicine medicine.disease_cause medicine.disease Lesion Zidovudine Acquired immunodeficiency syndrome (AIDS) medicine Lack of efficacy Neoplasm Sarcoma medicine.symptom business Kaposi's sarcoma medicine.drug |
Zdroj: | Archives of Dermatology. 127:1068 |
ISSN: | 0003-987X |
DOI: | 10.1001/archderm.1991.01680060144031 |
Popis: | To the Editor.— Epidemic Kaposi's sarcoma (KS) is a neoplasm frequently seen in the acquired immunodeficiency syndrome (AIDS).1Cutaneous lesions are pleomorphic, vary in color, and may be mistaken for bruises and nevi. It may remain localized, but usually undergoes rapid multicentric cutaneous and/or visceral spread, producing substantial morbidity. Although studies have shown the lack of efficacy of zidovudine alone for control of Kaposi's sarcoma,2it is often used for antiretroviral action in conjunction with antineoplastic therapy, which may have hematologic toxic effects.3We report a patient who developed thrombocytopenia while receiving zidovudine, which led to ecchymoses around his Kaposi's sarcoma lesions, simulating rapid intracutaneous spread of the neoplasm and clearing after withdrawal of the drug. Report of a Case.— A 32-year-old white homosexual human immunodeficiency virus (HIV)-positive man developed a biopsyproven KS lesion on his left upper arm in 1985. Subsequently, he developedPneumocystis cariniipneumonia |
Databáze: | OpenAIRE |
Externí odkaz: |